Cargando…

Molecular Basis of Spina Bifida: Recent Advances and Future Prospectives

BACKGROUND: Spina bifida (SB) (spinal neural tube [NT] defects) is basically caused by an abnormality at the closure of the NT. MATERIALS AND METHODS: Molecular researchers have now got new etiopathogenesis of the defective neural tube closure. Although molecular mechanisms in the SB is really impor...

Descripción completa

Detalles Bibliográficos
Autores principales: Panda, Prateek Kumar, Mallik, Kanhu Charan, Patel, Ranjankumar, Barik, Mayadhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601120/
https://www.ncbi.nlm.nih.gov/pubmed/31316638
http://dx.doi.org/10.4103/jpn.JPN_20_19
_version_ 1783431243442946048
author Panda, Prateek Kumar
Mallik, Kanhu Charan
Patel, Ranjankumar
Barik, Mayadhar
author_facet Panda, Prateek Kumar
Mallik, Kanhu Charan
Patel, Ranjankumar
Barik, Mayadhar
author_sort Panda, Prateek Kumar
collection PubMed
description BACKGROUND: Spina bifida (SB) (spinal neural tube [NT] defects) is basically caused by an abnormality at the closure of the NT. MATERIALS AND METHODS: Molecular researchers have now got new etiopathogenesis of the defective neural tube closure. Although molecular mechanisms in the SB is really important taxation for further work. We understand through the unique novel mutant responsible genes and modifying genes and included the different molecular aspects of SB from the available tools and databases and excluded the case reports. STATISTICAL ANALYSIS: We use here simple statistics (percentage, mean, median, and average) through the Statistical Package for the Social Sciences (SPSS), version 14, and found P > 0.0001 to be significant. RESULTS: We have reported that the majority of 90% genes are responsible in SB and their associated diseases. These innovative unique patterns of responsible genes attached with the result abnormalities at the neuronal and non neuronal tissues are equally important for the SB and NTC. CONCLUSION: Our present ideology is aiming to understand the inductive and direct interactions of the downstream target sites among responsible regulating genes (RRGs). It is an unique pattern of genetic roadmap to control and guides the neurulation and may provide further insights into the causes of SB and may help to develop new molecular-targeted therapy (MTT).
format Online
Article
Text
id pubmed-6601120
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-66011202019-07-17 Molecular Basis of Spina Bifida: Recent Advances and Future Prospectives Panda, Prateek Kumar Mallik, Kanhu Charan Patel, Ranjankumar Barik, Mayadhar J Pediatr Neurosci Original Article BACKGROUND: Spina bifida (SB) (spinal neural tube [NT] defects) is basically caused by an abnormality at the closure of the NT. MATERIALS AND METHODS: Molecular researchers have now got new etiopathogenesis of the defective neural tube closure. Although molecular mechanisms in the SB is really important taxation for further work. We understand through the unique novel mutant responsible genes and modifying genes and included the different molecular aspects of SB from the available tools and databases and excluded the case reports. STATISTICAL ANALYSIS: We use here simple statistics (percentage, mean, median, and average) through the Statistical Package for the Social Sciences (SPSS), version 14, and found P > 0.0001 to be significant. RESULTS: We have reported that the majority of 90% genes are responsible in SB and their associated diseases. These innovative unique patterns of responsible genes attached with the result abnormalities at the neuronal and non neuronal tissues are equally important for the SB and NTC. CONCLUSION: Our present ideology is aiming to understand the inductive and direct interactions of the downstream target sites among responsible regulating genes (RRGs). It is an unique pattern of genetic roadmap to control and guides the neurulation and may provide further insights into the causes of SB and may help to develop new molecular-targeted therapy (MTT). Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6601120/ /pubmed/31316638 http://dx.doi.org/10.4103/jpn.JPN_20_19 Text en Copyright: © 2019 Journal of Pediatric Neurosciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Panda, Prateek Kumar
Mallik, Kanhu Charan
Patel, Ranjankumar
Barik, Mayadhar
Molecular Basis of Spina Bifida: Recent Advances and Future Prospectives
title Molecular Basis of Spina Bifida: Recent Advances and Future Prospectives
title_full Molecular Basis of Spina Bifida: Recent Advances and Future Prospectives
title_fullStr Molecular Basis of Spina Bifida: Recent Advances and Future Prospectives
title_full_unstemmed Molecular Basis of Spina Bifida: Recent Advances and Future Prospectives
title_short Molecular Basis of Spina Bifida: Recent Advances and Future Prospectives
title_sort molecular basis of spina bifida: recent advances and future prospectives
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601120/
https://www.ncbi.nlm.nih.gov/pubmed/31316638
http://dx.doi.org/10.4103/jpn.JPN_20_19
work_keys_str_mv AT pandaprateekkumar molecularbasisofspinabifidarecentadvancesandfutureprospectives
AT mallikkanhucharan molecularbasisofspinabifidarecentadvancesandfutureprospectives
AT patelranjankumar molecularbasisofspinabifidarecentadvancesandfutureprospectives
AT barikmayadhar molecularbasisofspinabifidarecentadvancesandfutureprospectives